Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Apr 15:305:92-98.
doi: 10.1016/j.ijcard.2020.02.008. Epub 2020 Feb 4.

Quality of life and the associated risk of all-cause mortality in nonischemic heart failure

Affiliations
Randomized Controlled Trial

Quality of life and the associated risk of all-cause mortality in nonischemic heart failure

Johan S Bundgaard et al. Int J Cardiol. .

Abstract

Objectives: To examine the association between health-related quality of life (HRQoL) and mortality in patients with heart failure (HF).

Background: The potential association of HRQoL and mortality in patients with HF is unclear. We investigated this association in The Danish Study to Assess the Efficacy of Implantable Cardioverter Defibrillators (ICD) in Patients with Non-ischemic Systolic Heart Failure on Mortality (DANISH).

Methods: In DANISH, a total of 1116 patients with non-ischemic systolic HF on guideline-recommended therapy were randomized to ICD therapy or usual clinical care. HRQoL was assessed at randomization using the disease-specific Minnesota Living with Heart Failure Questionnaire (MLHFQ, 0-105, high score indicating worse HRQoL). Multivariable Cox proportional hazard models were used to compare hazard ratios (HR) for all-cause mortality according to MLHFQ above or below 45, as recommended by a recent meta-analysis, to identify patients with poor HRQoL.

Results: HRQoL was completed by 935 (84%) patients at baseline with a median follow-up of 67 months (IQR 47-83). Patients with poor HRQoL (MLHFQ score > 45, median 60 (IQR 53-71),n = 350) had a higher incidence of all-cause mortality than patients with moderate/good HRQoL (MLHFQ ≤45, median 23 (IQR 13-33), n = 585), respectively 26% vs. 18% with an unadjusted HR of 1.57 (95% CI 1.19-2.08, p = .002), and an adjusted HR of 1.39 (95% CI 1.01-1.91, p = .04).

Conclusion: Poor HRQoL was associated with an increased risk of all-cause mortality after adjustment for traditional risk factors.

Clinical trial registration: https: //clinicaltrials.gov/ct2/show/NCT00542945(DANISH).

Keywords: All-cause mortality; Health-related quality of life; Heart failure.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Dr. Køber reports receiving lecture fees from Novartis. Dr. Thune reports receiving lecture fees from Novartis. Dr. Nielsen reports receiving support from the Novo Nordisk Foundation (NNF16OC0018658 and NNF17OC0029148).

Publication types

Associated data